Meini, Simone http://orcid.org/0000-0002-8711-8305
Tascini, Carlo
Cei, Marco
Sozio, Emanuela
Rossolini, Gian Maria
Article History
Received: 24 October 2018
Accepted: 23 February 2019
First Online: 6 March 2019
Compliance with ethical standards
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest.
: In the past 2 years, C.T. has been paid for lectures on behalf of Pfizer, Novartis, Merck, Angelini, Gilead, and Astellas. G.M.R. has received research grants from Angelini, Basilea, Menarini, Merck, Nordic Pharma, Pfizer, Rempex, Shionogi, VenatorX, Zambon; has received congress lecture fees from Angelini, Basilea, Merck, Pfizer, Zambon; has received consultancy fees from Angelini, Menarini, Merck, Nordic Pharma, Pfizer, Rempex, Shionogi, Zambon. The other authors have nothing to declare. All authors read and approved the final manuscript.